Top Clinical Trials companies in South Korea by Price to Earnings Ratio (P/E)
South Korea
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
-1.25 |
Jan. 14, 2025 | USD 1.17 | -3.48% |
|
South Korea |
|
| 2 |
-2.18 |
Jan. 14, 2025 | USD 1.67 | -1.86% |
|
South Korea |
|
| 3 |
-3.13 |
Jan. 14, 2025 | USD 3.70 | 0.18% |
|
South Korea |
|
| 4 |
-3.68 |
Jan. 14, 2025 | USD 3.10 | -1.75% |
|
South Korea |
|
| 5 |
-12.69 |
Jan. 14, 2025 | USD 10.57 | -0.48% |
|
South Korea |
|
| 6 |
-35.88 |
Jan. 14, 2025 | USD 17.25 | 0.74% |
|
South Korea |
|
| 7 |
-482.83 |
Jan. 14, 2025 | USD 21.07 | 1.40% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Price to Earnings Ratio (P/E) ?
The Clinical Trials company in South Korea with the highest Price to Earnings Ratio (P/E) is Gencurix Inc. (KOSDAQ: 229000.KQ) at -1.25.
-
Which Clinical Trials company in South Korea has the lowest Price to Earnings Ratio (P/E) ?
The Clinical Trials company in South Korea with the lowest Price to Earnings Ratio (P/E) is ABL Bio Inc. (KOSDAQ: 298380.KQ) at -482.83.
-
What are the top 10 Clinical Trials companies in South Korea by Price to Earnings Ratio (P/E) ?
The top 10 Clinical Trials companies in South Korea by Price to Earnings Ratio (P/E) are Gencurix Inc., GeneOne Life Science, Inc., Genexine, Inc., MedPacto, Inc., OliX Pharmaceuticals,Inc, Oscotec Inc. and ABL Bio Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Price to Earnings Ratio (P/E) ?
The bottom 10 Clinical Trials companies in South Korea by Price to Earnings Ratio (P/E) are ABL Bio Inc., Oscotec Inc., OliX Pharmaceuticals,Inc, MedPacto, Inc., Genexine, Inc., GeneOne Life Science, Inc. and Gencurix Inc..